Rhoen Klinikum AG
OTC:RKAGY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rhoen Klinikum AG
OTC:RKAGY
|
DE |
|
Boatim Inc
OTC:BTIM
|
US |
|
V
|
Vidis SA
WSE:VDS
|
PL |
|
Viasat Inc
LSE:0LPE
|
US |
|
N
|
National Beverage Corp
LSE:0K50
|
US |
|
Union Insurance Co Ltd
TWSE:2816
|
TW |
|
Aker ASA
OSE:AKER
|
NO |
|
EDM Resources Inc
XTSX:EDM
|
CA |
|
G
|
Grenke AG
XBER:GLJ
|
DE |
|
Banco Santander SA
LSE:0HLE
|
ES |
|
S
|
Societe Anonyme des Bains de Mer et du Cercle des Etrangers a Monaco SA
LSE:0O80
|
MC |
|
C
|
Compass Group PLC
OTC:CMPGY
|
UK |
|
NameSilo Technologies Corp
OTC:URLOF
|
CA |
|
Soleno Therapeutics Inc
NASDAQ:SLNO
|
US |
|
I
|
Ion Beam Applications SA
SWB:IOB
|
BE |
Wall St Price Targets
RKAGY Price Targets Summary
Rhoen Klinikum AG
According to Wall Street analysts, the average 1-year price target for RKAGY is 9.51 USD with a low forecast of 8.31 USD and a high forecast of 11.06 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RKAGY's stock price target?
Price Target
9.51
USD
According to Wall Street analysts, the average 1-year price target for RKAGY is 9.51 USD with a low forecast of 8.31 USD and a high forecast of 11.06 USD.
What is the Revenue forecast for Rhoen Klinikum AG?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been -3%. The projected CAGR for the next 5 years is 5%.
What is the Operating Income forecast for Rhoen Klinikum AG?
Projected CAGR
20%
Over the last 14 years, the compound annual growth rate for Operating Income has been -11%. The projected CAGR for the next 5 years is 20%.
What is the Net Income forecast for Rhoen Klinikum AG?
Projected CAGR
19%
Over the last 14 years, the compound annual growth rate for Net Income has been -10%. The projected CAGR for the next 5 years is 19%.
